Duane Pinto, MD
Interventional Cardiology · Boston, MANPI 1275521130
Payments from drug & device makers
Across 583 payments — averaging $7229.88 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- CSL Behring$3M
- Boston Scientific$730K
- Abbott$225K
- Medtronic$119K
- Abiomed$109K
- Terumo Medical Corporation$18K
- plus $62K from 17 others
Across 5 payments — averaging $171.00 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.
- Novo Nordisk AS$555
- Boston Scientific$300
What the payments were for
- Consulting fees$249,75251%
- Speaking & faculty fees$151,21331%
- Travel & lodging$68,81814%
- Food & beverage$20,8564%
- Gifts$100%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| CSL Behring | 56 | $2,951,896 |
| Boston Scientific | 64 | $730,340 |
| Abbott | 228 | $224,887 |
| Medtronic(2 entities) | 84 | $118,907 |
| Abiomed | 80 | $108,886 |
| Terumo Medical Corporation | 28 | $17,843 |
| Neovasc Medical Inc | 3 | $17,702 |
| Gilead | 7 | $14,205 |
| Magenta Medical Inc | 6 | $9,249 |
| Vascular Solutions, Inc. | 1 | $6,000 |
| Biotronik Inc. | 10 | $5,756 |
| Haemonetics Corporation | 1 | $3,000 |
| Opsens Inc. | 1 | $2,000 |
| Shockwave Medical, Inc | 1 | $1,500 |
| Inari Medical, Inc. | 1 | $1,000 |
| Cordis US CORP. | 1 | $667 |
| Siemens Medical Solutions USA, Inc. | 4 | $376 |
| Cathworks, Inc. | 1 | $261 |
| Arrow International, Inc. | 2 | $186 |
| Philips North America LLC | 1 | $147 |
| Saranas, Inc. | 1 | $108 |
| Edwards Lifesciences | 1 | $82 |
| Corindus Inc. | 1 | $25 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- OPTIS$124,652
- Impella$108,274
- Xience V coronary stent system$41,006
- DRAGONFLY OPSTAR$32,107
- Resolute$23,004
- GENERAL - THERAPIES$13,747
- ADVISOR$12,122
- LOTUS EDGE$10,816
- GENERAL - STRUCTURAL HEART$7,139
- MANTA$6,153
- GlideWire$5,152
- METACROSS OTW$5,152
- COREVALVE EVOLUT R$3,793
- RESOLUTE ONYX$3,375
- Azur CX Detachable$3,336
- TEG6s HEMOSTASIS SYSTEM$3,000
- GLIDESHEATH SLENDER$2,941
- Perclose ProGlide suture mediated closure system$2,250
- OptoWire$2,000
- OptoMonitor$2,000
How this compares
$4,215,021 in reported general payments places this provider in the 95th percentile of 128 interventional cardiology providers in Massachusetts.
See all interventional cardiology providers in Massachusetts →
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Other interventional cardiology in Boston
- Charles GibsonBoston$16.3M
- Eric SecemskyBoston$7.3M
- Suzanne BaronBoston$3.9M
- Pinak ShahBoston$3M
- Robert YehBoston$2.1M
- Jeffrey PopmaBoston$1.9M
- Roger LahamBoston$1.2M
- Farouc JafferBoston$900K
- Darshan DoshiBoston$838K
- Nicola MaschiettoBoston$540K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.